These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11694315)

  • 21. Vaccination of apoptotic Fas ligand-expressing tumors decreased antitumor responses by enhanced production of immunosuppressive cytokines.
    Wada A; Tada Y; Shimozato O; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
    Anticancer Res; 2005; 25(1A):299-303. PubMed ID: 15816551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
    Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
    J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies.
    da Fonseca AC; Badie B
    Clin Dev Immunol; 2013; 2013():264124. PubMed ID: 23864876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FasL gene knock-down therapy enhances the antiglioma immune response.
    Jansen T; Tyler B; Mankowski JL; Recinos VR; Pradilla G; Legnani F; Laterra J; Olivi A
    Neuro Oncol; 2010 May; 12(5):482-9. PubMed ID: 20406899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline.
    Hu F; Ku MC; Markovic D; Dzaye O; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
    Int J Cancer; 2014 Dec; 135(11):2569-78. PubMed ID: 24752463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of P2X4 receptor in rat C6 glioma by tumor-associated macrophages and activated microglia.
    Guo LH; Trautmann K; Schluesener HJ
    J Neuroimmunol; 2004 Jul; 152(1-2):67-72. PubMed ID: 15223238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune microenvironment of gliomas.
    Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
    Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells.
    Tada Y; O-Wang J; Takiguchi Y; Tatsumi K; Kuriyama T; Okada S; Tokuhisa T; Sakiyama S; Tagawa M
    J Immunol; 2002 Sep; 169(5):2241-5. PubMed ID: 12193688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
    Shinohara H; Yagita H; Ikawa Y; Oyaizu N
    Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats.
    Sasaki A; Yokoo H; Tanaka Y; Homma T; Nakazato Y; Ohgaki H
    Neuropathology; 2013 Oct; 33(5):505-14. PubMed ID: 23331472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
    Dzaye O; Hu F; Derkow K; Haage V; Euskirchen P; Harms C; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
    J Neuropathol Exp Neurol; 2016 May; 75(5):429-40. PubMed ID: 27030742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Fas/Fas ligand system and cancer: immune privilege and apoptosis.
    Abrahams VM; Kamsteeg M; Mor G
    Mol Biotechnol; 2003 Sep; 25(1):19-30. PubMed ID: 13679631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-specific immune response to implanted gliomas.
    Proescholdt MA; Merrill MJ; Ikejiri B; Walbridge S; Akbasak A; Jacobson S; Oldfield EH
    J Neurosurg; 2001 Dec; 95(6):1012-9. PubMed ID: 11765816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas.
    Badie B; Schartner JM
    Neurosurgery; 2000 Apr; 46(4):957-61; discussion 961-2. PubMed ID: 10764271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular interactions between tumor and its microenvironment in malignant gliomas.
    Ellert-Miklaszewska A; Pasierbinska M; Poleszak K; Kamińska B
    Postepy Biochem; 2018 Oct; 64(2):129-140. PubMed ID: 30656895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?
    Saas P; Walker PR; Hahne M; Quiquerez AL; Schnuriger V; Perrin G; French L; Van Meir EG; de Tribolet N; Tschopp J; Dietrich PY
    J Clin Invest; 1997 Mar; 99(6):1173-8. PubMed ID: 9077524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of RCAS1 protein in microglia/macrophages accompanying brain tumours. An immunofluorescence study.
    Adamek D; Radwańska E; Gajda M
    Folia Neuropathol; 2009; 47(3):240-6. PubMed ID: 19813143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.